- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Antiretroviral Therapy, Highly Active" OR HAART (15 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT00796263 | Recruiting | Antiretroviral Therapy for Acute HIV Infection |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
536 | All | 18 Years and older (Adult, Senior) | NCT00796263 | HAART for Acute HIV infection | AAHIV | April 2009 | April 2021 | July 2021 | November 24, 2008 | April 19, 2018 |
|
|
2 | NCT03149211 | Not yet recruiting | To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
375 | All | 20 Years and older (Adult, Senior) | NCT03149211 | UBP-A304-HIV | September 2018 | December 2021 | December 2021 | May 11, 2017 | October 26, 2017 | |||
3 | NCT00267865 | Recruiting | Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
28 | All | 18 Years to 99 Years (Adult, Senior) | NCT00267865 | 060051 06-C-0051 |
December 16, 2005 | July 31, 2019 | July 31, 2021 | December 21, 2005 | April 4, 2018 |
|
||
4 | NCT02563509 | Recruiting | Reconstitution of HIV-specific Immunity Against HIV |
|
|
Interventional | Phase 1 |
|
Other |
|
|
40 | All | 16 Years to 60 Years (Child, Adult) | NCT02563509 | 2013ZX10001004 | January 2013 | June 2017 | December 2017 | September 30, 2015 | May 23, 2017 |
|
||
5 | NCT03366922 | Not yet recruiting | Evaluation of Artemisia Annua and Moringa |
|
|
Interventional | Not Applicable |
|
Other |
|
|
282 | All | 18 Years and older (Adult, Senior) | NCT03366922 | 27/05-17 | December 10, 2017 | December 10, 2019 | December 10, 2019 | December 8, 2017 | December 8, 2017 | |||
6 | NCT01697540 | Recruiting | Management of Highly Active Anti-retroviral Therapy-related Hyperlipidemia Among HIV-infected Patients in Taiwan |
|
Observational |
|
Other |
|
100 | All | Child, Adult, Senior | NCT01697540 | KMUHIRB-2012-05-05(I) | September 2012 | September 2019 | October 2, 2012 | April 28, 2017 |
|
||||||
7 | NCT02945163 | Recruiting | Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
184 | All | 18 Years to 60 Years (Adult) | NCT02945163 | 2016-M-2 | March 5, 2018 | June 30, 2019 | October 31, 2019 | October 26, 2016 | March 22, 2018 |
|
||
8 | NCT01428596 | Recruiting | Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
30 | All | 18 Years to 60 Years (Adult) | NCT01428596 | A010 | GCHT01 | September 2010 | December 2017 | December 2017 | September 5, 2011 | April 24, 2017 |
|
|
9 | NCT02276326 | Recruiting | Effects of VSL#3 on Neuro-cognitive Profile of HIV Patients |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 18 Years and older (Adult, Senior) | NCT02276326 | VSL-Dett 2014 | July 2014 | December 2016 | March 2018 | October 28, 2014 | December 5, 2016 |
|
||
10 | NCT02415985 | Recruiting | Pharmacokinetics and Safety of Rifabutin 150 mg Once Daily Versus Rifabutin 300 mg Thrice Weekly |
|
|
Interventional | Phase 2 |
|
Other |
|
|
40 | All | 18 Years to 60 Years (Adult) | NCT02415985 | HIV-NAT 116 | June 2015 | September 2018 | September 2018 | April 14, 2015 | August 10, 2017 |
|
||
11 | NCT03037372 | Not yet recruiting | Statin Adjunct Therapy Among ART-treated Adults in Sub-Saharan Africa: Atorvastatin and Rosuvastatin Equivalence Trial |
|
|
Interventional | Phase 3 |
|
Other |
|
|
320 | All | 18 Years to 90 Years (Adult, Senior) | NCT03037372 | DN2017 | STAR | June 1, 2017 | June 30, 2022 | December 31, 2022 | January 31, 2017 | January 31, 2017 | ||
12 | NCT01161199 | Recruiting | The Use of Leukapheresis to Support HIV Pathogenesis Studies |
|
|
Observational |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT01161199 | H52899-34904-01 | July 2010 | July 2020 | July 2020 | July 13, 2010 | August 18, 2015 |
|
|||
13 | NCT02431975 | Recruiting | Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial |
|
|
Interventional | Phase 4 |
|
Other / NIH |
|
|
60 | All | up to 48 Hours (Child) | NCT02431975 | AAAO5011 U01HD080441 |
LEOPARD | August 2015 | July 31, 2020 | July 31, 2020 | May 1, 2015 | July 21, 2017 |
|
|
14 | NCT00476606 | Recruiting | A Prospective Cohort of Children With HIV Infection |
|
|
Observational |
|
Other |
|
|
1000 | All | up to 20 Years (Child, Adult) | NCT00476606 | HIV-NAT 015 | March 2003 | December 2020 | December 2020 | May 22, 2007 | February 24, 2017 |
|
|||
15 | NCT01137981 | Recruiting | Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects |
|
|
Observational |
|
Industry |
|
|
1 | Female | Child, Adult, Senior | NCT01137981 | 112885 WE066 (EPIP095) EPI40018 |
February 15, 1993 | December 31, 2024 | December 31, 2024 | June 7, 2010 | October 24, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.